Medtronic - 43 Year Stock Price History | MDT
- The all-time high Medtronic stock closing price was 122.32 on September 08, 2021.
- The Medtronic 52-week high stock price is 92.68, which is 14.4% above the current share price.
- The Medtronic 52-week low stock price is 75.96, which is 6.3% below the current share price.
- The average Medtronic stock price for the last 52 weeks is 84.56.
Medtronic Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 83.5820 | 80.8028 | 92.2700 | 76.2425 | 81.0300 | 0.84% |
2023 | 78.2674 | 73.8204 | 86.9518 | 67.1580 | 80.3542 | 9.61% |
2022 | 87.2511 | 97.0769 | 104.0854 | 71.1802 | 73.3111 | -22.55% |
2021 | 110.2252 | 103.9498 | 122.3230 | 90.5047 | 94.6522 | -9.81% |
2020 | 91.2371 | 100.2950 | 106.1957 | 63.8400 | 104.9533 | 5.67% |
2019 | 85.5325 | 75.3950 | 99.7988 | 70.7043 | 99.3232 | 27.33% |
2018 | 74.5701 | 69.3469 | 84.8436 | 64.5725 | 78.0019 | 14.51% |
2017 | 68.1128 | 58.5955 | 74.5488 | 58.5955 | 68.1153 | 15.23% |
2016 | 65.9798 | 61.5769 | 72.9873 | 59.0170 | 59.1100 | -5.44% |
2015 | 60.4393 | 57.2952 | 63.5402 | 52.1778 | 62.5115 | 8.62% |
2014 | 49.7351 | 44.7978 | 59.9861 | 41.9490 | 57.5502 | 28.13% |
2013 | 39.7758 | 32.0958 | 45.8264 | 32.0958 | 44.9152 | 42.88% |
2012 | 30.0663 | 28.7395 | 34.0243 | 26.9947 | 31.4367 | 10.64% |
2011 | 27.2025 | 27.0844 | 31.6486 | 22.4204 | 28.4126 | 5.81% |
2010 | 27.8852 | 31.0977 | 32.7540 | 22.4456 | 26.8527 | -13.81% |
2009 | 24.6346 | 22.6859 | 31.8061 | 16.9605 | 31.1544 | 42.53% |
2008 | 32.2572 | 33.8878 | 38.9537 | 19.8233 | 21.8581 | -36.33% |
2007 | 35.2660 | 35.6561 | 39.4246 | 30.9002 | 34.3282 | -5.22% |
2006 | 34.1301 | 38.8384 | 40.0389 | 28.6811 | 36.2179 | -6.29% |
2005 | 36.0647 | 32.9542 | 39.2681 | 32.5567 | 38.6504 | 16.72% |
2004 | 32.9126 | 32.1246 | 35.5209 | 30.8312 | 33.1142 | 2.68% |
2003 | 31.2635 | 30.7896 | 34.8261 | 28.4282 | 32.2507 | 7.23% |
2002 | 29.1887 | 32.7928 | 32.7928 | 22.1917 | 30.0772 | -10.35% |
2001 | 30.3254 | 38.8001 | 38.8001 | 25.5094 | 33.5478 | -14.80% |
2000 | 33.3988 | 22.2490 | 39.7782 | 22.2490 | 39.3739 | 66.33% |
1999 | 23.6230 | 23.6356 | 28.5367 | 20.2987 | 23.6716 | -1.49% |
1998 | 18.7938 | 16.1243 | 24.8100 | 14.7136 | 24.0303 | 42.11% |
1997 | 13.1392 | 10.7943 | 16.9102 | 9.3652 | 16.9102 | 55.23% |
1996 | 9.2064 | 8.2843 | 11.0346 | 7.5170 | 10.8936 | 22.37% |
1995 | 6.6574 | 4.2531 | 9.5397 | 4.2230 | 8.9024 | 101.79% |
1994 | 3.5164 | 3.2432 | 4.4117 | 2.7777 | 4.4117 | 36.94% |
1993 | 2.8081 | 3.6908 | 3.6908 | 2.0785 | 3.2217 | -13.04% |
1992 | 3.2614 | 3.5956 | 4.0257 | 2.4861 | 3.7048 | 1.94% |
1991 | 2.4105 | 1.6134 | 3.6343 | 1.5236 | 3.6343 | 119.73% |
1990 | 1.4372 | 1.2423 | 1.7547 | 1.1321 | 1.6540 | 32.89% |
1989 | 0.9900 | 0.7286 | 1.3252 | 0.7286 | 1.2446 | 71.39% |
1988 | 0.7650 | 0.8841 | 0.9212 | 0.6477 | 0.7262 | -15.76% |
1987 | 0.8314 | 0.7114 | 0.9969 | 0.6094 | 0.8621 | 21.78% |
1986 | 0.6574 | 0.3983 | 0.8380 | 0.3983 | 0.7079 | 76.71% |
1985 | 0.3147 | 0.2486 | 0.4052 | 0.2348 | 0.4006 | 61.14% |
1984 | 0.2782 | 0.3960 | 0.4006 | 0.2325 | 0.2486 | -34.96% |
1983 | 0.4502 | 0.4962 | 0.5456 | 0.3730 | 0.3822 | -22.60% |
1982 | 0.3867 | 0.3568 | 0.5157 | 0.3131 | 0.4938 | 39.73% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $102.570B | $32.364B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
Stryker (SYK) | United States | $136.147B | 30.68 |
Boston Scientific (BSX) | United States | $130.670B | 37.57 |
EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
ResMed (RMD) | United States | $33.995B | 27.93 |
Terumo (TRUMY) | Japan | $28.800B | 40.67 |
Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
Insulet (PODD) | United States | $17.996B | 71.67 |
Baxter (BAX) | United States | $14.756B | 9.60 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
Demant (WILYY) | Denmark | $7.926B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
Haemonetics (HAE) | United States | $3.862B | 18.85 |
ICU Medical (ICUI) | United States | $3.751B | 35.71 |
Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
Envista Holdings (NVST) | United States | $3.103B | 23.11 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
Neogen (NEOG) | United States | $2.605B | 30.05 |
LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
AtriCure (ATRC) | United States | $1.465B | 0.00 |
InMode (INMD) | Israel | $1.444B | 8.68 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
Owens & Minor (OMI) | United States | $0.973B | 7.60 |
CeriBell (CBLL) | United States | $0.958B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
Evolus (EOLS) | United States | $0.688B | 0.00 |
Omeros (OMER) | United States | $0.593B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
Surmodics (SRDX) | United States | $0.572B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
Quanterix (QTRX) | United States | $0.383B | 0.00 |
ZimVie (ZIMV) | United States | $0.373B | 31.44 |
Valneva SE (VALN) | France | $0.353B | 0.00 |
Biote (BTMD) | United States | $0.313B | 6.86 |
Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
Cerus (CERS) | United States | $0.293B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
Zynex (ZYXI) | United States | $0.268B | 56.00 |
High Tide (HITI) | Canada | $0.237B | 98.00 |
Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
Brainsway (BWAY) | Israel | $0.169B | 89.60 |
FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
Jin Medical (ZJYL) | China | $0.132B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.096B | 10.79 |
Veru (VERU) | United States | $0.092B | 0.00 |
Exagen (XGN) | United States | $0.083B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
InterCure (INCR) | Israel | $0.061B | 0.00 |
Apyx Medical (APYX) | United States | $0.059B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
Modular Medical (MODD) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Safety Shot (SHOT) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Agape ATP (ATPC) | $0.005B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 12.82 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |